Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 4/2020

01-10-2020 | SARS-CoV-2 | Letter to the Editor

Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology

Authors: Evangelos Tsiambas, Aristeidis Chrysovergis, Vasileios Papanikolaou, Nicholas Mastronikolis, Vasileios Ragos, Nikolaos Kavantzas, Andreas C. Lazaris, Efstratios Patsouris, Christos Riziotis, Minas Paschopoulos, Efthymios Kyrodimos

Published in: Pathology & Oncology Research | Issue 4/2020

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Wu A, Peng Y, Huang B et al (2020) Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microb 27(3):325–328CrossRef
2.
Lukassen S, Chua RL, Trefzer T et al (2020) SARS-CoV-2 Receptor ACE2 and TMPRSS2 Are Primarily Expressed in Bronchial Transient Secretory Cells. EMBO J e105114–118
3.
Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 176:104742–104747CrossRef
4.
Tsiambas E, Papanikolaou V, Chrysovergis A et al (2020) Coronavirus in hematologic malignancies: targeting molecules beyond the angiotensin-converting enzyme 2 (ACE2) wall. Pathol Oncol Res 1–3
5.
Buja LM, Wolf DA, Zhao B et al (2020) The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol 48:107233–107243CrossRef
6.
Lewnard JA, Liu VX, Jackson ML et al (2020) Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ 369:m1923–1933CrossRef
7.
Yamada S, Utsunomiya M, Inoue K et al (2004) Genome-wide Scan for Japanese Familial Intracranial Aneurysms: Linkage to Several Chromosomal Regions. Circulation 110:3727–3733CrossRef
8.
Zhong J, Yan Z, Liu D et al (2006) Association of Angiotensin-Converting Enzyme 2 Gene A/G Polymorphism and Elevated Blood Pressure in Chinese Patients With Metabolic Syndrome. J Lab Clin Med 147(2):91–95CrossRef
9.
Conti P, Younes A (2020) Coronavirus COV-19/SARS-CoV-2 Affects Women Less Than Men: Clinical Response to Viral Infection. J Biol Regul Homeost Agents 34(2)
10.
Li G, He X, Zhang L et al (2020) Assessing ACE2 Expression Patterns in Lung Tissues in the Pathogenesis of COVID-19. J Autoimmun:102463–49
11.
Sawalha AH, Zhao M, Coit P, Lu Q (2020) Epigenetic Dysregulation of ACE2 and Interferon-Regulated Genes Might Suggest Increased COVID-19 Susceptibility and Severity in Lupus Patients. Clin Immunol 215:108410–108415CrossRef
12.
Yamaguchi M, Osuka S, Shoji M, Weitzmann MN, Murata T (2017) Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro. Mol Cell Biochem 430(1–2):37–46CrossRef
13.
Wei X, Yu H, Zhao P, Xie L, Li L, Zhang J (2019) Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases. Braz J Med Biol Res 52(10):e8845–e8850CrossRef
Metadata
Title
Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology
Authors
Evangelos Tsiambas
Aristeidis Chrysovergis
Vasileios Papanikolaou
Nicholas Mastronikolis
Vasileios Ragos
Nikolaos Kavantzas
Andreas C. Lazaris
Efstratios Patsouris
Christos Riziotis
Minas Paschopoulos
Efthymios Kyrodimos
Publication date
01-10-2020
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2020
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-020-00878-0

Other articles of this Issue 4/2020

Pathology & Oncology Research 4/2020 Go to the issue

Original Article

Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma

Original Article

Expression of the Serrated Markers Annexin A10 or Gremlin1 in Colonic Adenocarcinomas: Morphology and Prognostic Values

Original Article

EGFRvIII-CAR-T Cells with PD-1 Knockout Have Improved Anti-Glioma Activity

Review

The Role of Interleukin-9 in Cancer

Original Article

AT-rich Interaction Domain 1A Gene Variations: Genetic Associations and Susceptibility to Gastric Cancer Risk

Letter to the Editor

Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits